[HTML][HTML] Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions
Background Vaccine induced immune medicated thrombocytopenia or VITT, is a recent and
rare phenomenon of thrombosis with thrombocytopenia, frequently including cerebral
venous thromboses (CVT), that has been described following vaccination with adenovirus
vaccines ChAdOx1 nCOV-19 (AstraZeneca) and Ad26. COV2· S Johnson and Johnson
(Janssen/J&J). The evaluation and management of suspected cases of CVT post COVID-19
vaccination are critical skills for a broad range of healthcare providers. Methods A …
rare phenomenon of thrombosis with thrombocytopenia, frequently including cerebral
venous thromboses (CVT), that has been described following vaccination with adenovirus
vaccines ChAdOx1 nCOV-19 (AstraZeneca) and Ad26. COV2· S Johnson and Johnson
(Janssen/J&J). The evaluation and management of suspected cases of CVT post COVID-19
vaccination are critical skills for a broad range of healthcare providers. Methods A …